Effects of aprotinin on anticoagulant monitoring: Implications in cardiovascular surgery
- 31 March 1993
- journal article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 55 (3) , 662-666
- https://doi.org/10.1016/0003-4975(93)90272-j
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Aprotinin therapy for reoperative myocardial revascularization: A placebo-controlled studyThe Annals of Thoracic Surgery, 1992
- Platelet protection by aprotinin in cardiopulmonary bypass: Electron microscopic studyThe Annals of Thoracic Surgery, 1992
- Hematologic disorders and ischemic stroke. A selective review.Stroke, 1990
- Aprotinin (Trasylol) is a competitive inhibitor of activated protein CThrombosis Research, 1989
- High-Dose Aprotinin: Hemostatic Effects in Open Heart OperationsThe Annals of Thoracic Surgery, 1989
- Reduction of Homologous Blood Requirement in Cardiac Surgery by Intraoperative Aprotinin Application - Clinical Experience in 152 Cardiac Surgical PatientsThe Thoracic and Cardiovascular Surgeon, 1989
- Reduction of Blood Transfusion Requirement in Open Heart Surgery by Administration of High Doses of Aprotinin - Preliminary ResultsThe Thoracic and Cardiovascular Surgeon, 1989
- The extrinsic fibrinolytic system in survivors of myocardial infarctionThrombosis Research, 1987
- TrasylolBiochemical Pharmacology, 1967